The tweet said, “Drug corporations’ greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a year,” and linked to a STAT article about the company’s price hikes. The tweet was not signed with a “-B,” indicating a staff member — not Sen. Sanders — wrote the post, according to the report.
Ariad raised the wholesale acquisition price of its leukemia drug Iclusig four times this year, according to STAT. The treatment costs more than $16,000 for a 30-day pack of pills, which amounts to $199,000 a year.
Cambridge, Mass.-based Ariad’s shares dropped 15 percent on Friday afternoon in response to the tweet, costing investors $387 million, according to the report.
More articles on supply chain:
Drug industry reaps new profits from opioid abuse crisis
3 takeaways from last week’s American Medical Device Summit
Trucking industry provides less financial support to Donald Trump than past Republican nominees: 4 things to know
